Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of GBP 289.50 billion. The enterprise value is 287.51 billion.

Market Cap	289.50B
Enterprise Value	287.51B

Important Dates

The next estimated earnings date is Wednesday, February 5, 2025.

Earnings Date	Feb 5, 2025
Ex-Dividend Date	Aug 16, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.86%
Shares Change (QoQ)	-0.11%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.16B

Valuation Ratios

The trailing PE ratio is 27.39.

PE Ratio	27.39
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	39.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.26, with an EV/FCF ratio of 33.14.

EV / Earnings	27.20
EV / Sales	9.57
EV / EBITDA	19.26
EV / EBIT	20.62
EV / FCF	33.14

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.47.

Current Ratio	0.94
Quick Ratio	0.74
Debt / Equity	0.47
Debt / EBITDA	0.42
Debt / FCF	0.73
Interest Coverage	825.54

Financial Efficiency

Return on equity (ROE) is 88.73% and return on invested capital (ROIC) is 52.81%.

Return on Equity (ROE)	88.73%
Return on Assets (ROA)	22.49%
Return on Capital (ROIC)	52.81%
Revenue Per Employee	420,062
Profits Per Employee	147,048
Employee Count	64,319
Asset Turnover	0.78
Inventory Turnover	1.23

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-13.50%
50-Day Moving Average	109.38
200-Day Moving Average	126.33
Relative Strength Index (RSI)	24.03
Average Volume (20 Days)	44,670

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of GBP 30.19 billion and earned 10.57 billion in profits. Earnings per share was 2.37.

Revenue	30.19B
Gross Profit	25.56B
Operating Income	14.00B
Pretax Income	13.31B
Net Income	10.57B
EBITDA	14.85B
EBIT	14.00B
Earnings Per Share (EPS)	2.37

Full Income Statement

Balance Sheet

The company has 8.36 billion in cash and 6.36 billion in debt, giving a net cash position of 2.00 billion.

Cash & Cash Equivalents	8.36B
Total Debt	6.36B
Net Cash	2.00B
Net Cash Per Share	n/a
Equity (Book Value)	13.45B
Book Value Per Share	3.02
Working Capital	-1.47B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.19 billion and capital expenditures -4.52 billion, giving a free cash flow of 8.68 billion.

Operating Cash Flow	13.19B
Capital Expenditures	-4.52B
Free Cash Flow	8.68B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 84.66%, with operating and profit margins of 46.37% and 35.01%.

Gross Margin	84.66%
Operating Margin	46.37%
Pretax Margin	44.07%
Profit Margin	35.01%
EBITDA Margin	49.19%
EBIT Margin	46.37%
FCF Margin	28.73%

Dividends & Yields

Novo Nordisk does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	36.47%
Years of Dividend Growth	7
Payout Ratio	46.60%
Buyback Yield	0.86%
Shareholder Yield	0.86%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on September 20, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 20, 2023
Split Type	Forward
Split Ratio	2

Scores

Novo Nordisk has an Altman Z-Score of 10.12.

Altman Z-Score	10.12
Piotroski F-Score	n/a